Talk:Grifola frondosa
From Wikipedia, the free encyclopedia
[edit] Pulled Section
The following section was formerly in the article, but it is not appropriate for Wikipedia, reading as an advertisement, containing non-notable research, and referenced by a source that I cannot seem to trace. אמר Steve Caruso 20:21, 13 November 2007 (UTC)
[edit] Maitake D-fraction
Most research on maitake has focused on the use of maitake D-fraction for treating various malignancies. D-fraction consists of a highly standardized and purified active beta-glucan (both -3-branched beta-1,6 glucan AND 6-branched beta-3 1.3 glucan), and approximately 30% of protein, extracted from maitake mushroom's fruiting body. The bioactive D-fraction, extracted from maitake, is prepared by a standardised procedure developed by "Maitake Products, Inc.", East Rutherford, New Jersey.
Active beta-glucans in D-fractions have unique polysaccharide structures, and the degree of branching is greater than any beta-glucan found in any other medicinal mushrooms that demonstrate similar immune stimulatory properties. Researchers theorize that the complexity of branching makes D-fraction most potent for enhancing the immune system via oral administration, leading to a higher tumor reduction in several animal studies.
Most other mushroom extracts fail to show oral activity in pre-clinical studies. The Memorial Sloan-Kettering Cancer Center in New York is conducting a study in collaboration with the New York Presbyterian Hospital-Weill Medical College of Cornell University to determine if D-fraction can stimulate the immune system, without causing any side effects or toxicity. Further laboratory studies and extensive clinical studies are under way in collaboration with leading research institutes, both in the United States and in Japan.
- Reference: Pahang Pharmacy. Maitake boost to the immune system, New Sunday Times, Malaysia, dated September 18, 2005.
This article or section is missing information about: SX-fraction.
This concern has been noted on the talk page where it may be discussed whether or not to include such information.(March 2008)
